Menu
Most people think Botox is a tool for plastic surgeons, and not urologists. But the Food and Drug Administration approved the drug about a year ago for women with overactive bladder symptoms when there is no apparent neurologic cause, reports Health Cleveland Clinic.
“The drug decreases the spasms that cause overactive bladder symptoms,” says Sandip Vasavada, MD, Urologic Director, Center for Female Urology and Reconstructive Pelvic Surgery, at Cleveland Clinic’s Glickman Urological Institute. “It’s not so much for frequency of urination, as much as that sudden urge to go. It’s good to help people when it’s something they can’t postpone without leakage occurring.”
Onabotulinum toxinA is frequently effective as long as patients repeat the treatment roughly once every six months, says Dr Vasavada.
The main side effect of the procedure, which occurs in about 5 to 8 percent of patients, is urinary retention, or problems emptying one’s bladder.
Those patients may need temporary catheterization to guard against an increased risk of urinary tract infections, Dr. Vasavada says. And for that reason, some patients decide against the onabotulinum toxinA procedure.
Read more.
Signup for our Free Automatic Delivery Program and save 5% on all automatic orders going forward. Click here to learn more.
© 2024, Healthwick Canada Powered by Shopify